Memo Therapeutics
acquired by ClementiaZurich, CH · Founded 2012 · 36 employees on LinkedIn · 12 known investors
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases. The company is a late-stage biotech enterprise collaborating with academic institutions and pharmaceutical partners to advance its pipeline.
Investors · 12
Kurma Partners✓ verifiedParis · $162K – $10.8M
Pureos Bioventures✓ verifiedPfäffikon
Ysios Capital✓ verifiedBarcelona · $5.4M – $21.6M
Adjuvant CapitalNew York · $10M – $25M
Fresenius Medical Care VenturesBad Homburg
.jpeg){kind=logo}
Verve VenturesZug · $1.1M – $2.2M
redalpinereportedZug · $108K – $2.2M
Also in the syndicate · 5
GF GroupRed AlpineSchroders CapitalSwisscantoVesalius Biocapital
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CMay 2024
Adjuvant Capital, Fresenius Medical Care Ventures, GF Group, Kurma Partners, Pureos Bioventures, Red Alpine, Schroders Capital, Swisscanto, Verve Ventures, Vesalius Biocapital, Ysios Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Memo Therapeutics do?
- Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases. The company is a late-stage biotech enterprise collaborating with academic institutions and pharmaceutical partners to advance its pipeline.
- Who are Memo Therapeutics's investors?
- Memo Therapeutics's investors include Kurma Partners, Pureos Bioventures, Ysios Capital, Adjuvant Capital, Fresenius Medical Care Ventures, Verve Ventures, redalpine.
- Who acquired Memo Therapeutics?
- Memo Therapeutics was acquired by Clementia.
- Where is Memo Therapeutics headquartered?
- Memo Therapeutics is headquartered in Zurich, CH.